Vanguard Asset Management’s Definium Therapeutics DFTX Stock Holding History
Bought
Maintained
Sold
Other funds holding DFTX
Vanguard Asset Management's DFTX Position: Q3 2026 in Review
Vanguard Asset Management increased its Definium Therapeutics (DFTX) stake by 54% in Q3 2026, buying an estimated $1.78M and bringing the position to 120,728 shares worth $4.59M. The position accounts for ﹤0.01% of the portfolio, ranked #1091.
Vanguard Asset Management first reported a position in DFTX in Q1 2026 and has held it in 3 quarters since. 354 funds tracked by Wall St. Rank hold DFTX as of Q3 2026.
- Vanguard Asset Management held 120,728 shares of Definium Therapeutics worth $4.59M as of Q3 2026.
- Vanguard Asset Management bought 42,124 Definium Therapeutics shares in Q3 2026, an estimated $1.78M.
- Definium Therapeutics made up ﹤0.01% of Vanguard Asset Management's portfolio in Q3 2026, its #1091 holding.
- Vanguard Asset Management first reported a position in Definium Therapeutics in Q1 2026 and has held it in 3 quarters since.
- 354 funds tracked by Wall St. Rank held Definium Therapeutics as of Q3 2026.
Based on Vanguard Asset Management's 13F filing for Q3 2026, filed 13 Nov 2026.